Literature DB >> 22268970

Endoscopic topical application of Ankaferd Blood Stopper® in gastrointestinal bleeding.

Ahmet Karaman1, Mevlut Baskol, Sebnem Gursoy, Edip Torun, Alper Yurci, Mehmet Celikbilek, Kadri Guven, Omer Ozbakir, Mehmet Yucesoy.   

Abstract

AIM: This was a prospective study investigating the efficacy of Ankaferd Blood Stopper(®) (ABS), an herbal preparation, in patients with upper gastrointestinal (UGI) bleeding.
MATERIALS AND METHODS: A total of 30 patients (22 male, 8 female) who had UGI bleeding (with differing causes) were included in the study. ABS was used to stop the bleeding.
RESULTS: Primary hemostasis was achieved in 26 of the 30 cases.
CONCLUSIONS: ABS is an effective and safe agent to use in patients with UGI bleeding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22268970     DOI: 10.1089/acm.2010.0827

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  9 in total

1.  CEGP-003 Spray Has a Similar Hemostatic Effect to Epinephrine Injection in Cases of Acute Upper Gastrointestinal Bleeding.

Authors:  Byoung Wook Bang; Don Haeng Lee; Hyung Kil Kim; Kye Sook Kwon; Yong Woon Shin; Su Jin Hong; Jong Ho Moon
Journal:  Dig Dis Sci       Date:  2018-07-27       Impact factor: 3.199

2.  Massive haematuria successfully managed by intravesical Ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation.

Authors:  Yalcin Solak; Abduzhappar Gaipov; Orhan Ozbek; Mustafa Aziz Hassan; Mehdi Yeksan
Journal:  BMJ Case Rep       Date:  2012-12-23

3.  Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study.

Authors:  Cagri Akalin; Serdar Kuru; Aziz Mutlu Barlas; Kemal Kismet; Bugra Kaptanoglu; Aydin Demir; Hesna Muzeyyen Astarci; Huseyin Ustun; Ertugrul Ertas
Journal:  Int Wound J       Date:  2012-09-03       Impact factor: 3.315

4.  Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids.

Authors:  Ahmet Koluman; Nejat Akar; Umit Y Malkan; Ibrahim C Haznedaroglu
Journal:  Biomed Res Int       Date:  2016-01-26       Impact factor: 3.411

5.  Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level.

Authors:  Emre Huri; Engin Dogantekin; Murvet Hayran; Umit Yavuz Malkan; Mine Ergun; Aysegul Firat; Yavuz Beyazit; Huseyin Ustun; Murat Kekilli; Mumtaz Dadali; Muzeyyen Astarci; Ibrahim C Haznedaroglu
Journal:  Springerplus       Date:  2016-11-08

6.  Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases.

Authors:  Ahmet Koluman; Nejat Akar; İbrahim C Haznedaroğlu
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

7.  Efficacy of a novel endoscopically deliverable muco-adhesive hemostatic powder in an acute gastric bleeding porcine model.

Authors:  ByoungWook Bang; Eunhye Lee; JinHee Maeng; Keunsu Kim; Joo Ha Hwang; Suong-Hyu Hyon; Woogi Hyon; Don Haeng Lee
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

Review 8.  Hemostatic powders for gastrointestinal bleeding: a review of old, new, and emerging agents in a rapidly advancing field.

Authors:  Shirley X Jiang; Daljeet Chahal; Nabil Ali-Mohamad; Christian Kastrup; Fergal Donnellan
Journal:  Endosc Int Open       Date:  2022-08-15

9.  Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model.

Authors:  Emre Huri; Yavuz Beyazit; Rashad Mammadov; Sila Toksoz; Ayse B Tekinay; Mustafa O Guler; Huseyin Ustun; Murat Kekilli; Mumtaz Dadali; Tugrul Celik; Müzeyyen Astarci; Ibrahim C Haznedaroglu
Journal:  Int J Biomater       Date:  2013-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.